All the information you need about SPFPL POLY PHARMA HOLDING to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-01-19 | Public | 2021-02-28 | Complete |
| 2021-03-11 | Public | 2020-02-29 | Complete |
| 2020-02-05 | Public | 2019-02-28 | Complete |
| 2019-01-29 | Public | 2018-02-28 | Complete |
| 2018-05-14 | Public | 2017-02-28 | Complete |
| Name | SPFPL POLY PHARMA HOLDING |
| Siren | 822526380 |
| Closing | 2018-02-28 |
| Registry code | 3405 |
| Registration number | 839 |
| Management number | 2016D01412 |
| Activity code | 6420Z |
| Closing date n-1 | 2017-02-28 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 06 |
| Filing date | 2019-01-29 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 34000 MONTPELLIER |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BJ TOTAL (I) | 9 070 329.00 | |||
CF Cash and cash equivalents | 1 334.00 | |||
CJ TOTAL (II) | 1 334.00 | |||
CO Grand total (0 to V) | 9 071 663.00 | |||
CS Evaluated investments - equity method | 9 070 329.00 | |||
CW Deferred expenses or loan issuance costs | ||||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 1 000.00 | 1 000.00 | 1 000.00 | |
DB Share, merger, contribution premiums, etc. | 200.00 | 200.00 | 200.00 | |
DH Retained earnings | -12 769.00 | -12 769.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | -512 626.00 | -12 769.00 | -512 626.00 | |
DL TOTAL (I) | -524 195.00 | -11 569.00 | -524 195.00 | |
DS Convertible Bond Issues | 2 604 862.00 | 2 400 000.00 | 2 604 862.00 | |
DU Loans and Debts from Credit Institutions (3) | 4 091 292.00 | 4 100 015.00 | 4 091 292.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 1 000 000.00 | 1 000 000.00 | 1 000 000.00 | |
DY Tax and social security liabilities | 26 607.00 | 26 607.00 | ||
EA Other liabilities | 1 873 097.00 | 1 100 000.00 | 1 873 097.00 | |
EC TOTAL (IV) | 9 595 858.00 | 8 600 015.00 | 9 595 858.00 | |
EE Grand total (I to V) | 9 071 663.00 | 8 588 446.00 | 9 071 663.00 | |
EG Accrued income and payables due within one year | 451 876.00 | 4 500 015.00 | 451 876.00 | |
EH Including current bank overdrafts and credit balances from banks and postal accounts | 27 941.00 | 15.00 | 27 941.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 15 365.00 | |||
GF Total Operating Expenses (II) | 15 365.00 | |||
GG - OPERATING RESULT (I - II) | -15 365.00 | |||
GR Interest and similar expenses | 497 260.00 | |||
GU Total financial expenses (VI) | 497 260.00 | |||
GV - FINANCIAL INCOME (V - VI) | -497 260.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -512 626.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 512 626.00 | 12 769.00 | 512 626.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | -512 626.00 | -12 769.00 | -512 626.00 | |
